How Much Does Wegovy Cost on the NHS — and What If You Don't Qualify?

Is Wegovy actually free on the NHS, and who can get it?

The NHS does fund Wegovy (semaglutide 2.4mg) for weight management, but it is not available through a GP in the usual sense. NICE's guidance on semaglutide for weight management (TA875) recommends it only within specialist weight management services, for adults with a BMI of 35 or above (with at least one weight-related condition), and for a maximum of two years. Ethnic-background thresholds are typically 2.5 kg/m² lower under UK guidance. Meeting those numbers does not guarantee access, patients also need to be enrolled in a multidisciplinary programme that combines the medicine with diet and activity support.

In practice, that means a referral to a tier-3 or tier-4 weight management service, followed by a wait. In many NHS areas that wait is considerable. If you want to understand the NHS criteria in granular detail, our page on Wegovy's NHS pricing and access breaks them down alongside what the phased rollout means regionally.

So to answer the original question directly: if you qualify and gain access, you pay only your standard prescription charge (or nothing if you are exempt). The medicine itself is not invoiced to the patient. The obstacle is qualifying and getting seen, not the price. For a full breakdown of what Wegovy costs per month on the NHS in the UK, including how prescription charges and exemptions interact with the funding model, we cover that in detail separately.

What does Wegovy actually cost in the private market?

For people who fall outside NHS criteria or who prefer not to wait, private treatment is an option, but it requires understanding what you are really paying for. Private Wegovy pricing in the UK is quoted per pen or per month, and it changes as the dose escalates through the maintenance schedule. The 0.25mg and 0.5mg starter pens cost less than the 1.7mg and 2.4mg maintenance doses; a patient partway through their titration journey is paying a different amount each month. Our Wegovy price chart maps this across the full schedule so you can see how costs shift over time.

Reported private market prices since mid-2025 have ranged roughly from £149 to £375 per month depending on the dose and the provider, though figures move and individual providers set their own levels. Those headline numbers, however, often represent the medicine alone. What sits alongside it (the consultation, the clinical oversight, the repeat review) is what separates providers. A bare per-pen price that looks lower on the surface may carry an attached consultation fee, a prescription charge on top, or a delivery cost that a different provider bundles in.

For a clearer look at how the 2.4mg maintenance dose is priced specifically, our 2.4mg Wegovy cost page gives the context you need.

What does a Wegovy price typically exclude, and why does that matter?

This is the question worth sitting with before comparing two numbers side by side. Providers structure their pricing differently, and a lower headline figure does not always mean a lower total cost. Common add-ons that are not always folded into a quoted price include: an initial consultation fee, a prescription-issuance fee, delivery charges (often per order), and ongoing dose-review support when you want to move up the titration ladder.

Aftercare is worth particular attention. A prescriber should review your progress before issuing each repeat prescription, that is the standard set by the NHS England wraparound care guidance for weight-management injections. If that clinical review is not built into the price, it either does not happen (a safety gap) or it appears as a separate charge.

At nume, the position is deliberate and stated plainly: we are not the cheapest option you will find. One price covers the consultation, the prescription, the medicine, and next-working-day tracked delivery, with aftercare access seven days a week and a clinical re-review before every repeat. Nothing is added at checkout. You can see current treatment pricing on our weight-loss treatments page; we do not publish per-pen prices in editorial copy because the right starting point is whether you are clinically suitable, not whether a number looks appealing.

Why is 'cheapest Wegovy' the wrong thing to search for?

Wegovy is a prescription-only medicine. The MHRA has repeatedly warned about counterfeit and illegally sourced weight-loss pens sold online, including fake pens that have contained insulin rather than semaglutide. The tell-tale signs are prices far below market rates, sellers on social media, and offers that do not mention a clinical assessment. A price that looks like a bargain is one of the clearest red flags to watch for. You can report suspect sellers directly at the MHRA's Yellow Card scheme.

The right metric for a prescription medicine is not the cheapest listing, it is whether the supply is genuine, the clinical oversight is real, and the pharmacy is verifiable. You can confirm any online pharmacy's GPhC registration at the GPhC register; nume's registration number is 9012878. Every pen we dispense comes through the licensed UK supply chain, sourced from Novo Nordisk's authorised distribution network.

If you are exploring whether private treatment is right for you, or whether NHS criteria apply to your situation, the practical next step is a consultation, not a price comparison. Our prescribers are there to answer both questions. Check your eligibility with a free consultation today.